Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Matheson AJ, Perry CM. Glucosamine: a review of its use in the management of osteoarthritis. Drugs Aging 2003; 20(14): 1041–60
Rotta Pharmaceuticals. Glucosamine sulfate: summary of product characteristics. Milan: Rotta Pharmaceuticals, 1999
Setnikar I, Palumbo R, Canali S, et al. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43(10): 1109–13
Noack W, Fischer M, Förster KK, et al. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2(1): 51–9
Reichelt A, Förster KK, Fischer M, et al. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee: a randomised, placebo-controlled, double-blind study. Arzneimittel Forschung 1994; 44(1): 75–80
Giacovelli G, Rovati LC. Clinical efficacy of glucosamine sulfate in osteoarthritis of the spine [abstract no. Mo 96]. Rev Esp Reumatol 1993 Jul; 20 Suppl. 1: 325
Müller-Faßbender H, Bach GL, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 61–9
Qiu GX, Gao SN, Giacovelli G, et al. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittel Forschung 1998 May; 48(5): 469–74
Rovati LC. The clinical profile of glucosamine sulfate as a selective symptom modifying drug in osteoarthritis: current data and perspectives [abstract no. sym.20]. Osteoarthritis Cartilage 1997; 5: 72
Lopes-Vaz A. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin 1982; 8(3): 145–9
Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001 Jan 27; 357: 251–6
Pavelká K, Gatterová J, Olejarová M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002 Oct 14; 162: 2113–23
Richy F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003 Jul 14; 163: 1514–22
Rights and permissions
About this article
Cite this article
Glucosamine improves symptoms of osteoarthritis, but further studies on its disease-modifying effects are needed. Drugs Ther. Perspect 20, 1–4 (2004). https://doi.org/10.2165/00042310-200420100-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420100-00001